Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive function in recent-onset demyelinating diseases.

O Lyon-Caen, R Jouvent, S Hauser

    Archives of Neurology
    |November 1, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Attribution of mental States to others by schizophrenic patients.

    Cognitive neuropsychiatry·2014
    Same author

    [Traumatic neuroses. 1958].

    L'Encephale·2010
    Same author

    Semantic inhibition disorders in schizophrenic patients assessed by a lexical decision task.

    European psychiatry : the journal of the Association of European Psychiatrists·2009
    Same author

    Emotional deficit: an adaptative and evolutive process in HIV infection.

    European psychiatry : the journal of the Association of European Psychiatrists·2009
    Same author

    Are there differential effects of fluoxetine in retarded/blunted affect versus agitated/anxious depressives? A clinical study.

    European psychiatry : the journal of the Association of European Psychiatrists·2009
    Same author

    Abducens nucleus syndrome due to pontine haemorrhage.

    Cerebrovascular diseases (Basel, Switzerland)·2006
    Same journal

    Incorrect Table Entries and Word.

    Archives of neurology·2016
    Same journal

    IDEAL for CCSVI Research-Reply.

    Archives of neurology·2013
    Same journal

    Atlas of Inherited Metabolic Diseases, 3rd ed.

    Archives of neurology·2013
    Same journal

    Error in byline: in heterogeneity of coenzyme q10 deficiency: patient study and literature review.

    Archives of neurology·2013
    Same journal

    This month in archives of neurology.

    Archives of neurology·2013
    Same journal

    About this journal.

    Archives of neurology·2013
    See all related articles

    Cognitive impairment affects 60% of patients with recent demyelinating diseases like multiple sclerosis (MS). These early deficits impact visual and verbal skills, highlighting the need for early diagnosis.

    Area of Science:

    • Neuroscience
    • Neurology
    • Cognitive Science

    Background:

    • Recent demyelinating diseases, including multiple sclerosis (MS) and optic neuritis, can present with subtle or no overt cognitive impairment.
    • Understanding early cognitive changes is crucial for timely diagnosis and management of these neurological conditions.

    Purpose of the Study:

    • To investigate the prevalence and nature of cognitive disturbances in patients with early-stage multiple sclerosis (MS) and isolated optic neuritis.
    • To assess the relationship between cognitive impairment and disease activity, handicap, or depressive status in recent demyelinating diseases.

    Main Methods:

    • Studied 30 patients with definite/probable MS (duration < 2 years) or recent optic neuritis, all without clinical cognitive impairment.
    • Administered neuropsychological tests to assess visual and verbal efficiency.

    Related Experiment Videos

  • Compared patient results to a control group of 29 individuals.
  • Main Results:

    • Mild to moderate cognitive impairment was detected in 18 (60%) of the 30 patients, affecting visual and/or verbal functions.
    • These cognitive abnormalities were statistically significant compared to the control group.
    • No correlation was found between cognitive impairment and depressive status, disease handicap, or disease activity.

    Conclusions:

    • Cognitive dysfunction is prevalent (60%) even in the early stages of demyelinating diseases like MS.
    • Neuropsychological testing may aid in diagnosing early or subtle forms of MS.
    • Further research is needed to understand the natural history of cognitive functions in MS.